FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381598453> ?p ?o ?g. }

• W4381598453 endingPage "2699" @default.
• W4381598453 startingPage "2699" @default.
• W4381598453 abstract "(1) Background: Upfront treatment consolidation with high-dose chemotherapy (HDCT) and autologous stem cell transplantation (ASCT) has relevantly contributed to achieving durable remissions following induction treatment in multiple myeloma (MM) patients. The optimization of HDCT regimens can, therefore, essentially contribute to improving the depth and duration of tumor remissions. To date, melphalan at 200 mg/m2 is the standard HDCT regimen for fit MM patients. In our previous work, we showed promising efficacy and safety results for treosulfan (14 g/m2) and melphalan (200 mg/m2) (TreoMel) in acute myeloid leukemia (AML) patients receiving ASCT. Based on these data, TreoMel became the standard of care for fit MM patients at our institution. (2) Methods: We identified 115 consecutive MM patients who underwent consolidation with TreoMel between 01/2020 and 08/2022 at the University Hospital of Bern. We analyzed the safety and efficacy data, as well as the treosulfan pharmacokinetics, correlating them with tumor responses. (3) Results: A complete response (CR) rate of 84% was achieved, which is comparable to the CR rate reported for the quadruplet combination. The median PFS was 30 months (95% CI: 20.4-not reached), and the 31-month OS rate was 83%. The median area under the curve (AUC) for treosulfan was 952.5 mg*h/L (range: 527.4-1781.4), and the median peak level was 332.3 mg/L (range: 168-554). The treosulfan pharmacokinetics showed no significant correlation with MM responses after HDCT and ASCT. However, female patients had a significantly higher AUC (p = 0.007) and peak value (p = 0.001), and the higher values were associated with longer hospitalizations. (4) Conclusions: Treatment consolidation with TreoMel HDCT demonstrated a promising efficacy and safety profile in our cohort of MM patients and deserves further investigation in prospective studies." @default.
• W4381598453 created "2023-06-23" @default.
• W4381598453 creator A5030595810 @default.
• W4381598453 creator A5039411921 @default.
• W4381598453 creator A5043205605 @default.
• W4381598453 creator A5043426460 @default.
• W4381598453 creator A5055898889 @default.
• W4381598453 creator A5071805546 @default.
• W4381598453 creator A5073753205 @default.
• W4381598453 creator A5076011224 @default.
• W4381598453 creator A5092232384 @default.
• W4381598453 date "2023-05-10" @default.
• W4381598453 modified "2023-09-25" @default.
• W4381598453 title "Efficacy and Safety of High-Dose Chemotherapy with Treosulfan and Melphalan in Multiple Myeloma" @default.
• W4381598453 cites W2010977839 @default.
• W4381598453 cites W2017331060 @default.
• W4381598453 cites W2057300307 @default.
• W4381598453 cites W2102591890 @default.
• W4381598453 cites W2137040543 @default.
• W4381598453 cites W2160052421 @default.
• W4381598453 cites W2164807675 @default.
• W4381598453 cites W2530363241 @default.
• W4381598453 cites W2530375062 @default.
• W4381598453 cites W2542103229 @default.
• W4381598453 cites W2567333386 @default.
• W4381598453 cites W2590572482 @default.
• W4381598453 cites W2604776612 @default.
• W4381598453 cites W2766709436 @default.
• W4381598453 cites W2787699231 @default.
• W4381598453 cites W2793670020 @default.
• W4381598453 cites W2924570035 @default.
• W4381598453 cites W2940396472 @default.
• W4381598453 cites W3017173611 @default.
• W4381598453 cites W3019889711 @default.
• W4381598453 cites W3082868445 @default.
• W4381598453 cites W3145716452 @default.
• W4381598453 cites W3157661490 @default.
• W4381598453 cites W3158356424 @default.
• W4381598453 cites W3159410118 @default.
• W4381598453 cites W3200351501 @default.
• W4381598453 cites W4200606527 @default.
• W4381598453 cites W4210734847 @default.
• W4381598453 cites W4212987163 @default.
• W4381598453 cites W4224275732 @default.
• W4381598453 cites W4225516110 @default.
• W4381598453 cites W4229058450 @default.
• W4381598453 cites W4229446243 @default.
• W4381598453 cites W4234259363 @default.
• W4381598453 cites W4252175385 @default.
• W4381598453 cites W4281628749 @default.
• W4381598453 cites W4281700680 @default.
• W4381598453 cites W4283364154 @default.
• W4381598453 doi "https://doi.org/10.3390/cancers15102699" @default.
• W4381598453 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37345036" @default.
• W4381598453 hasPublicationYear "2023" @default.
• W4381598453 type Work @default.
• W4381598453 citedByCount "0" @default.
• W4381598453 crossrefType "journal-article" @default.
• W4381598453 hasAuthorship W4381598453A5030595810 @default.
• W4381598453 hasAuthorship W4381598453A5039411921 @default.
• W4381598453 hasAuthorship W4381598453A5043205605 @default.
• W4381598453 hasAuthorship W4381598453A5043426460 @default.
• W4381598453 hasAuthorship W4381598453A5055898889 @default.
• W4381598453 hasAuthorship W4381598453A5071805546 @default.
• W4381598453 hasAuthorship W4381598453A5073753205 @default.
• W4381598453 hasAuthorship W4381598453A5076011224 @default.
• W4381598453 hasAuthorship W4381598453A5092232384 @default.
• W4381598453 hasBestOaLocation W43815984531 @default.
• W4381598453 hasConcept C126322002 @default.
• W4381598453 hasConcept C126894567 @default.
• W4381598453 hasConcept C141071460 @default.
• W4381598453 hasConcept C143998085 @default.
• W4381598453 hasConcept C2776364478 @default.
• W4381598453 hasConcept C2776694085 @default.
• W4381598453 hasConcept C2777408962 @default.
• W4381598453 hasConcept C2778684742 @default.
• W4381598453 hasConcept C2779178397 @default.
• W4381598453 hasConcept C2780611847 @default.
• W4381598453 hasConcept C2781413609 @default.
• W4381598453 hasConcept C2911091166 @default.
• W4381598453 hasConcept C71924100 @default.
• W4381598453 hasConceptScore W4381598453C126322002 @default.
• W4381598453 hasConceptScore W4381598453C126894567 @default.
• W4381598453 hasConceptScore W4381598453C141071460 @default.
• W4381598453 hasConceptScore W4381598453C143998085 @default.
• W4381598453 hasConceptScore W4381598453C2776364478 @default.
• W4381598453 hasConceptScore W4381598453C2776694085 @default.
• W4381598453 hasConceptScore W4381598453C2777408962 @default.
• W4381598453 hasConceptScore W4381598453C2778684742 @default.
• W4381598453 hasConceptScore W4381598453C2779178397 @default.
• W4381598453 hasConceptScore W4381598453C2780611847 @default.
• W4381598453 hasConceptScore W4381598453C2781413609 @default.
• W4381598453 hasConceptScore W4381598453C2911091166 @default.
• W4381598453 hasConceptScore W4381598453C71924100 @default.
• W4381598453 hasIssue "10" @default.
• W4381598453 hasLocation W43815984531 @default.
• W4381598453 hasLocation W43815984532 @default.
• W4381598453 hasOpenAccess W4381598453 @default.

• next